| Size: 291 Ko 16th Sep 2026 Improving Gout Care in a Canadian Academic Medical Centre Through a Multidisciplinary Nurse-led Program | Size: 142 Ko 16th Sep 2026 A dwarf overshadowing a giant | Size: 202 Ko 16th Sep 2026 A Special Case of Antiphospholipid Syndrome | Size: 205 Ko 16th Sep 2026 Occult Pan-Aortitis in a Patient with Reactive Arthritis | Size: 179 Ko 16th Sep 2026 Refractory Gout: A Potential Sign of a Life-Threatening Disease | Size: 171 Ko 16th Sep 2026 Conduction Disorders/Dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis | Size: 171 Ko 16th Sep 2026 Conduction Disorders/Dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis | Size: 220 Ko 16th Sep 2026 Rotavirus Vaccine in Offspring Exposed to Tumour Necrosis Factor Inhibitors Does Not Increase Diarrhea-Associated Healthcare Events: Real-World Evidence to Guide Best Practices | Size: 190 Ko 16th Sep 2026 Variants génétiques associés aux fractures atypiques des fémurs, une revue narrative de la littérature | Size: 173 Ko 16th Sep 2026 Arthritis & Cannabis Use: Evaluating Disease and Psychosocial Factors Associated With Being a Regular User | Size: 165 Ko 16th Sep 2026 Chimeric antigen receptor (CAR) T cell therapy in primary Sjögren syndrome associated non-Hodgkin lymphoma: a case report | Size: 230 Ko 16th Sep 2026 Medication-related Hospitalizations in Patients with Systemic Lupus Erythematosus | Size: 165 Ko 16th Sep 2026 Les caractéristiques radiologiques de la pneumopathie interstitielle d’apparition tardive associée à la sclérodermie systémique. | Size: 180 Ko 16th Sep 2026 Safety & immUnogenicity of COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED): Preliminary Results on Severe Adverse Events | Size: 218 Ko 16th Sep 2026 Variation in tacrolimus whole blood concentrations during pregnancy and its implications for therapeutic drug monitoring: A systematic literature review | Size: 171 Ko 16th Sep 2026 Les prédicteurs de progression de la pneumopathie légère dans la sclérodermie systémique | Size: 188 Ko 16th Sep 2026 Characterization of incident interstitial lung disease in late systemic sclerosis | Size: 219 Ko 16th Sep 2026 Évolution des causes spécifiques de décès dans la maladie osseuse de Paget au Québec et comparaison à la population générale
| Size: 200 Ko 17th Sep 2026 Tumour Necrosis Factor Inhibitor Use and Discontinuation Among Pregnant Women with Chronic Inflammatory Diseases | Size: 167 Ko 17th Sep 2026 Therapeutic drug monitoring of azathioprine and tacrolimus in SLE pregnancies: Preliminary results from the LEGACY cohort | Size: 166 Ko 17th Sep 2026 Diagnostic Performance of a Newly-Launched Canadian Fast-Tract Ultrasound Clinic Performed by Rheumatologists for the Diagnosis of Giant Cell Arteritis | Size: 193 Ko 17th Sep 2026 Développement d’un cours en ligne accrédité sur la médecine de précision destiné aux rhumatologues et résidents en rhumatologie de la province de Québec. | Size: 170 Ko 17th Sep 2026 Polymyalgia Rheumatica and Interstitial Lung Disease: a Case Series | Size: 192 Ko 17th Sep 2026 Giant Cell Arteritis in a Patient with Limited Systemic Sclerosis Treated with Tocilizumab; A Case Report | Size: 168 Ko 17th Sep 2026 Retrospective study on the role of quantitative chest computed tomography in predicting disease progression in mild scleroderma-related interstitial lung disease. | Size: 224 Ko 17th Sep 2026 Safety and ImmUnogenicity of COVID-19 vaCCines in systemic immune mediated inflammatory Diseases (SUCCEED): Preliminary results
| Size: 110 Ko 16th Sep 2026 Cross-Sectional Study on Factors Associated with Symptoms of Anxiety among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study | Size: 106 Ko 16th Sep 2026 Cross-Sectional Study on Factors Associated with Symptoms of Depression among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study | Size: 123 Ko 16th Sep 2026 Effectiveness and safety of tofacitinib in Canadian patients with rheumatoid arthritis with vs without cardiovascular risk factors: a subgroup analysis of the multicentre, observational CANTORAL study | Size: 149 Ko 16th Sep 2026 Use and Perceptions of Nutrition Information Resources Among People with Systemic Sclerosis from the Scleroderma Patient-centered Intervention Network (SPIN) Cohort | Size: 107 Ko 16th Sep 2026 Effectiveness and safety of tofacitinib in Canadian patients with rheumatoid arthritis: primary results from a multicentre, observational study | Size: 118 Ko 16th Sep 2026 Seronegative Polyarthritis in Association with Anti-NXP2 Autoantibodies: A Case Series and Literature Review | Size: 102 Ko 16th Sep 2026 A Cross-Sectional Study of Factors Associated with Sleep Disturbance in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study
| Size: 6 Mo 5th Jun 2019 Revelations and Continued Mysteries in Rheumatoid Arthritis | Size: 9 Mo 5th Jun 2019 How Useful is Ultrasound in RA | Size: 5 Mo 5th Jun 2019 Mise à jour sur les vasculites systémiques des petits vaisseaux (VPV) | Size: 5 Mo 5th Jun 2019 Giant cell arteritis: are we moving beyond a biopsy? | Size: 10 Mo 5th Jun 2019 The Treatment of Systemic Lupus Erythematosus – Past Imperfect; Future Tense | Size: 2 Mo 5th Jun 2019 Lupus: A Case of Female Discrimination | Size: 135 Ko 17th Sep 2026 The Differential Expression of CLEC12A on Neutrophils of Rheumatoid arthritis Patients Correlates with Clinical Parameters. | Size: 137 Ko 17th Sep 2026 JAK Inhibitors: a Promising Molecular-Targeted Therapy in Dermatomyositis. | Size: 138 Ko 17th Sep 2026 Severe Axial and Pelvi-femoral Muscle Damage in Immune-Mediated Necrotizing Myopathy evaluated by Whole-body MRI. | Size: 133 Ko 17th Sep 2026 Association Between Immunosuppressive Therapy and Course of Mild Interstitial Lung Disease in Systemic Scleroderma. | Size: 135 Ko 17th Sep 2026 No Time to Lose: A Case of Severe Multifocal Aneurysmal Vasculitis. | Size: 134 Ko 17th Sep 2026 Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus. | Size: 135 Ko 17th Sep 2026 Effects of Strength Training on Participation and Health Related Quality of Life in Rheumatoid Arthritis. | Size: 135 Ko 17th Sep 2026 Comparison of first biologic drug persistence in patients with ankylosis spondylitis and non-radiographic axial spondyloarthritis: data from the SPARCC registry. | Size: 136 Ko 17th Sep 2026 Identifying Barriers and Facilitators to Physical Activity for People with Scleroderma: A Nominal Group Technique Study. | Size: 136 Ko 17th Sep 2026 Probability of Achieving Low Disease Activity or Remission in Subjects With Active Psoriatic Arthritis Treated With Apremilast. | Size: 137 Ko 17th Sep 2026 Achievement of cDAPSA Low Disease Activity or Remission Is Associated With Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in Subjects Treated With Apremilast. | Size: 138 Ko 17th Sep 2026 Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program. | Size: 139 Ko 17th Sep 2026 Physical Activity Monitoring using Wrist-Worn Accelerometer in the Assessment of Patients with Myositis. | Size: 135 Ko 17th Sep 2026 Stressful Life Events are Relation to RA Diagnosis and Presenting Characteristics: Results from the Canadian Early Arthritis Cohort (CATCH).
| Size: 197 Ko 17th Sep 2026 Potential communication failures at hospital discharge may compromise SLE care | Size: 197 Ko 17th Sep 2026 Thick as Thieves: A curious Case of Sjögren's Syndrome | Size: 197 Ko 17th Sep 2026 Myosite anti PM-SCL75 | Size: 198 Ko 17th Sep 2026 A Unique Case of Stevens–Johnson Syndrome and Giant Cell Arteritis | Size: 196 Ko 17th Sep 2026 Vasculite du système nerveux central à BCG | Size: 196 Ko 17th Sep 2026 Structure-Function Analysis of Clec12A, an Inhibitory Receptor Associated with Chronic Inflammatory Diseases | Size: 200 Ko 17th Sep 2026 Consistent Safety Profile With Up to 4 Years of Apremilast Treatment: Analysis of Data From 1,493 Subjects With Psoriatic Arthritis in 3 Large, Phase III, Long-term Studies | Size: 199 Ko 17th Sep 2026 Characterization of Clinical Benefits in Subjects Classified as ACR20 Non-responders at Week 104 of Apremilast Treatment: Subanalysis of 3 Long-term, Phase III Trials | Size: 200 Ko 17th Sep 2026 Low Rates of Major Adverse Cardiac Events, Malignancies, and Serious Infections in Subjects With Psoriasis and Psoriatic Arthritis Treated With Apremilast for ≥156 Weeks: Pooled Analysis From the ESTEEM and PALACE 1-3 Phase 3 Trials | Size: 200 Ko 17th Sep 2026 Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of OPAL Balance, an open-label, long-term extension study | Size: 198 Ko 17th Sep 2026 Marital status and age of systemic lupus erythematous diagnosis | Size: 195 Ko 17th Sep 2026 Fatigue Measurements in Systemic Lupus Erythematosus | Size: 198 Ko 17th Sep 2026 The Prevalence of Electrocardiographic Conduction Abnormalities in Systemic Sclerosis is very Similar to that found in Healthy Individuals: Data from the Canadian Scleroderma Research Group | Size: 198 Ko 17th Sep 2026 Cardiac magnetic resonance imaging role in systemic sclerosis-associated pulmonary hypertension: Analysis of 78 patients. | Size: 196 Ko 17th Sep 2026 Pulmonary Hypertrophic Osteoarthropathy in a Cystic Fibrosis Patient. | Size: 201 Ko 17th Sep 2026 Body Composition and Bone Health Among Sedentary Young Adults with and without Inflammatory Arthritis
| Size: 50 Ko 17th Sep 2026 Joint Pain in Relation to Changes in Weight and Body Composition in People Undergoing Bariatric Surgery | Size: 52 Ko 17th Sep 2026 Syndrome de Mullin | Size: 52 Ko 17th Sep 2026 Time to Pregnancy in Women with Systemic Lupus Erythematosus | Size: 51 Ko 17th Sep 2026 La maladie de Behçet intestinal | Size: 52 Ko 17th Sep 2026 The association of sociodemographic and disease variables with hand function: A Scleroderma Patient-centred Intervention Network (SPIN) Cohort study | Size: 51 Ko 17th Sep 2026 Experience with tofacitinib in Canada: Rheumatoid arthritis patient characteristics and treatment patterns from 2014 to 2016 | Size: 50 Ko 17th Sep 2026 Prevalence of Joint Pain Before and After Bariatric Surgery and Impact on Physical Activity | Size: 47 Ko 17th Sep 2026 Implementation and evaluation of inflammatory arthritis models of care in Canada | Size: 49 Ko 17th Sep 2026 CLINICAL CHARACTERISTICS OF SPONDYLARTHRITIS WITH AND WITHOUT PERIPHERAL ENTHESITIS – DATA FROM THE DESIR COHORT | Size: 50 Ko 17th Sep 2026 Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-World | Size: 48 Ko 17th Sep 2026 Real-World Efficacy of Anti-TNF in Psoriatic Arthritis Patients with Enthesitis and Correlation of Enthesitis with Tender / Swollen Joints | Size: 47 Ko 17th Sep 2026 Informal Caregivers for Scleroderma Focus Groups | Size: 47 Ko 17th Sep 2026 Exploring coping strategies among people living with scleroderma through focus groups: A Scleroderma Patient-centered Intervention Network Study | Size: 50 Ko 29th Mar 2018 Joint Pain in Relation to Changes in Weight and Body Composition in People Undergoing Bariatric Surgery | Size: 52 Ko 29th Mar 2018 Syndrome de Mullin | Size: 52 Ko 29th Mar 2018 Time to Pregnancy in Women with Systemic Lupus Erythematosus | Size: 51 Ko 29th Mar 2018 La maladie de Behçet intestinal | Size: 52 Ko 29th Mar 2018 The association of sociodemographic and disease variables with hand function: A Scleroderma Patient-centred Intervention Network (SPIN) Cohort study | Size: 51 Ko 29th Mar 2018 Experience with tofacitinib in Canada: Rheumatoid arthritis patient characteristics and treatment patterns from 2014 to 2016 | Size: 50 Ko 29th Mar 2018 Prevalence of Joint Pain Before and After Bariatric Surgery and Impact on Physical Activity | Size: 47 Ko 29th Mar 2018 Implementation and evaluation of inflammatory arthritis models of care in Canada | Size: 49 Ko 29th Mar 2018 CLINICAL CHARACTERISTICS OF SPONDYLARTHRITIS WITH AND WITHOUT PERIPHERAL ENTHESITIS – DATA FROM THE DESIR COHORT | Size: 50 Ko 29th Mar 2018 Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-World | Size: 48 Ko 29th Mar 2018 Real-World Efficacy of Anti-TNF in Psoriatic Arthritis Patients with Enthesitis and Correlation of Enthesitis with Tender / Swollen Joints | Size: 47 Ko 29th Mar 2018 Informal Caregivers for Scleroderma Focus Groups | Size: 47 Ko 29th Mar 2018 Exploring coping strategies among people living with scleroderma through focus groups: A Scleroderma Patient-centered Intervention Network Study | Size: 45 Ko 29th Mar 2018 Subclinical Enthesopathy in Psoriatic Patients and its Relation to Other Disease Parameters: An Ultrasound Study
| Size: 54 Ko 17th Sep 2026 Corrélation d’allèles de polymorphismes nucléotidiques (SNP) dans les gènes de l’interleukine-4 (IL-4) et de son récepteur (IL-4R) et du locus CD40 avec les issues cliniques et radiographiques chez des patients avec polyarthrite inflammatoire d’installation récente traités en visant la remission | Size: 50 Ko 17th Sep 2026 Rheumatic and Non-Rheumatic Autoimmune Diseases in SLE Offspring | Size: 56 Ko 17th Sep 2026 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (104-Week) Improvement in Fatigue in Patients With Psoriatic Arthritis: Pooled Results From 3 Phase III, Randomized, Controlled Trials | Size: 59 Ko 17th Sep 2026 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Improves Nail and Scalp Psoriasis and PASI Scores in Patients With Moderate to Severe Plaque Psoriasis. | Size: 63 Ko 17th Sep 2026 Clinical and histological improvement during 5 years of treatment of a woman with Muckle-Wells Syndrome | Size: 48 Ko 17th Sep 2026 Le cas de madame V: une histoire qui a du piquant. | Size: 305 Ko 17th Sep 2026 Lorsque la polychondrite récidivante atteint les lobes d’oreille… | Size: 44 Ko 17th Sep 2026 Un cas de calcinose extensive. | Size: 47 Ko 17th Sep 2026 Single-specificity anti-Ku antibodies in a tri-nation cohort of 2140 systemic sclerosis subjects: clinical associations | Size: 48 Ko 17th Sep 2026 Outcomes in mothers with rheumatic diseases and their offspring workshop | Size: 47 Ko 17th Sep 2026 Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: a Systematic Review | Size: 51 Ko 17th Sep 2026 Increased Risk of Allergic Conditions in Children Born to Women with SLE | Size: 46 Ko 17th Sep 2026 The Scleroderma Support Group Non-Attenders Survey: A Cross-sectional Study | Size: 43 Ko 17th Sep 2026 Exercise Habits and Associated Factors in Scleroderma: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study | Size: 51 Ko 17th Sep 2026 Risk of Ocular Anomalies in Children Exposed in Utero to Antimalarials: Data from the Offspring of SLE mothers Registry | Size: 43 Ko 17th Sep 2026 Risk of Lung Cancer in Rheumatoid Arthritis Patients | Size: 53 Ko 17th Sep 2026 Clinical Characteristics, Laboratory Findings and Nailfold Capillaroscopy Microscopy Patterns in a Monocentric Series of 123 Patients with Idiopathic Pernio | Size: 44 Ko 17th Sep 2026 Malignancy in juvenile idiopathic arthritis
| Size: 226 Ko 17th Sep 2026 Rôle de la résolvine D1 dans la régulation des réponses inflammatoires et cataboliques de l’arthrose | Size: 218 Ko 17th Sep 2026 A novel myopathy, two very different phenotypes: the French Canadian Experience. | Size: 228 Ko 17th Sep 2026 Atorvastatin-Induced Autoimmune Myopathy: An Emerging Dominant Entity in Patients with Autoimmune Myopathy Presenting with a Pure Polymyositis Phenotype. | Size: 223 Ko 17th Sep 2026 The anti-MDA5 autoantibody phenotype: Defining clinical, biochemical and radiological features suggestive of anti-MDA5-associated rapidly progressive interstitial lung disease. | Size: 229 Ko 17th Sep 2026 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (52-Week) Improvements in Enthesitis and Dactylitis in Patients With Psoriatic Arthritis: Pooled Results From Three Phase III, Randomized, Controlled Trials. | Size: 230 Ko 17th Sep 2026 Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC. | Size: 221 Ko 17th Sep 2026 Folate Supplementation and Cancer Risk in Rheumatoid Arthritis Patients Exposed to Methotrexate. | Size: 221 Ko 17th Sep 2026 Arthritis, gender, disability and incidence of Coronary Heart Disease: A longitudinal Canadian population-based cohort study. | Size: 219 Ko 17th Sep 2026 Alterations of the Non-Canonical WNT/PKC Pathway in Human Osteoarthritis Osteoblasts. | Size: 227 Ko 17th Sep 2026 Prevalence, Severity and Impact of Fecal Incontinence in Systemic Sclerosis: Preliminary Results of a Cross-Sectional Study. | Size: 220 Ko 17th Sep 2026 Resveratrol Regulates the WNT/ ß-Catenin Pathway in Human Osteoaarthritis Osteoblasts. | Size: 221 Ko 17th Sep 2026 Demographic and Disease Correlates of Clinically Significant Fatigue in Systemic Sclerosis: Preliminary Evidence Using Case-Definition Criteria. | Size: 220 Ko 17th Sep 2026 Sociodemographic and Disease Correlates of Fatigue in Systemic Sclerosis. | Size: 220 Ko 17th Sep 2026 Focus groups to inform the development of a scleroderma emotional distress coping tool. | Size: 220 Ko 17th Sep 2026 Risk of Breast, Ovarian and Endometrial Cancers in Women with Rheumatoid Arthritis. | Size: 219 Ko 17th Sep 2026 Breast, Ovarian and Endometrial Cancer in Women Diagnosed with SLE Before Age 40. | Size: 214 Ko 17th Sep 2026 Une polyarthrite chronique révélant une lèpre.
| Size: 229 Ko 17th Sep 2026 Further Reduction in Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With up to 7 Years in the FREEDOM Extension. | Size: 231 Ko 17th Sep 2026 Could Estrogen Impact a New Pertinent Gene for Adolescent Idiopathic Scoliosis (AIS)? | Size: 235 Ko 17th Sep 2026 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (52-Week) Improvement in Swollen and Tender Joint Counts in Patients With Psoriatic Arthritis: Results From Three Phase 3, Randomized, Controlled Trials. | Size: 226 Ko 17th Sep 2026 The pan-Canadian Approach to Inflammatory Arthritis Models of Care. Michel Zummer | Size: 233 Ko 17th Sep 2026 Depressive Symptoms at Baseline Predict Higher Simple Disease Activity Index (SDAI) Scores and Longer Time to Remission in Patients with Recent-Onset Arthritis. | Size: 227 Ko 17th Sep 2026 Ultrasound Doppler activity correlates with systemic autoimmunity and swollen joints in a healthy population at risk for rheumatoid arthritis. | Size: 230 Ko 17th Sep 2026 Redefining Dermatomyositis: Description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. | Size: 224 Ko 17th Sep 2026 Sous hypoxie, les fibroblastes synoviaux sains et arthritiques révèlent des altérations du métabolisme des sphingolipides. | Size: 232 Ko 17th Sep 2026 What investigations are needed to optimally monitor for malignancies in SLE? | Size: 224 Ko 17th Sep 2026 Management of fragility fracture: an integrated interdisciplinary approach. | Size: 232 Ko 17th Sep 2026 The role of marital satisfaction in emotional distress among women with scleroderma. | Size: 229 Ko 17th Sep 2026 Anti-Ro antibodies and cancer in Systemic Lupus Erythematosus. | Size: 231 Ko 17th Sep 2026 An international collaboration to conduct large-scale trials of non-pharmacological interventions in scleroderma: the Scleroderma Patient-centered Intervention Network (SPIN). | Size: 246 Ko 17th Sep 2026 Recurrent hypocalcemia following denosumab in a patient with short bowel and renal impairment. | Size: 235 Ko 17th Sep 2026 Can scores from English, French and Dutch versions of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) be pooled? An assessment of differential item functioning in patients with systemic sclerosis. | Size: 230 Ko 17th Sep 2026 Lien entre l’antagoniste DKK2 et la réponse à la PTH par les ostéoblastes humains ostéoarthrosiques. | Size: 225 Ko 17th Sep 2026 Estrogen receptor status and transcriptome profiling of genes regulated by 17-beta estradiol in human osteoblasts derived from idiopathic scoliosis patients. | Size: 227 Ko 17th Sep 2026 PPAR Υ controls mTOR/autophagy signalling in the articular cartilage. Faezeh Vasheghani Farahan
| Size: 226 Ko 17th Sep 2026 Les effets paradoxaux des agents anti-TNF | Size: 225 Ko 17th Sep 2026 Joint Action on Arthritis: A Framework to Improve Arthritis Prevention and Care in Canada. | Size: 239 Ko 17th Sep 2026 Denosumab Compared with Risedronate in Postmenopausal Women Suboptimally Adherent with Alendronate Therapy: Efficacy and Safety Results from a Randomized Open-Label Study. | Size: 224 Ko 17th Sep 2026 One-Year Results from the Canadian CAMEO Study: A Trial of Etanercept and Methotrexate versus Etanercept Alone in Rheumatoid Arthritis. | Size: 230 Ko 17th Sep 2026 The role of toll-like receptor-4 (TLR-4) activation in a murine model of systemic lupus erythematosus (SLE). | Size: 233 Ko 17th Sep 2026 Hypoxia in human osteoarthritic subchondral bone: a risk factor for leptin production by osteoblasts. | Size: 232 Ko 17th Sep 2026 Metabolic Factors, Biomechanical Stress and Estrogen Impact on Osteoblasts. | Size: 238 Ko 17th Sep 2026 Induced Abortions in Women with Systemic Sclerosis. | Size: 229 Ko 17th Sep 2026 A roadmap to personalized medicine in Rheumatoid Arthritis using anti-Sa antibody titers to monitor the immunopathologically driven, clinical disease activity. | Size: 240 Ko 17th Sep 2026 An Autoimmune Myositis-Overlap Syndrome Associated with Autoantibodies to Nuclear Pore Complexes. Description and Long-Term Follow-Up of the Anti-Nup Syndrome. | Size: 226 Ko 17th Sep 2026 Rheumatoid Arthritis Prevalence in Quebec. | Size: 236 Ko 17th Sep 2026 Measurement of Pulmonary Arteries by Cardiac Magnetic Resonance Imaging: A Simple and Useful Tool for the Detection of Pulmonary Hypertension in Systemic Sclerosis Patients without Overt Cardiac Microvascular Perfusion Defects or Fibrosis. | Size: 233 Ko 17th Sep 2026 Effects of Vitamin D Repletion and Maintenance Therapy on RA Characteristics and Quality of Life. | Size: 234 Ko 17th Sep 2026 Gender and Time to Diagnosis in Systemic Sclerosis: An Updated Analysis of 1,129 Patients from the Canadian Scleroderma Research Group Registry | Size: 228 Ko 17th Sep 2026 Expression of PPARa, b, g, and H- and L-PGDS during Osteoarthritis in the Spontaneous Hartley Guinea Pig and the Experimental Dog Models | Size: 241 Ko 17th Sep 2026 Low Prevalence of Myocardial Fibrosis by Cardiac Magnetic Resonance Imaging in 39 French Canadian Systemic Sclerosis Patients: Comparison of the CHUM Cohort with other World Cohorts. | Size: 237 Ko 17th Sep 2026 Prevalence of Current, 12-Month, and Lifetime Major Depressive Disorder among Patients with Systemic Sclerosis. | Size: 233 Ko 17th Sep 2026 Targeting fear of disease progression in rheumatic diseases: a case study in systemic sclerosis. | Size: 226 Ko 17th Sep 2026 H3K9 demethylation by LSD1 contributes to IL-1-induced mPGES-1 expression in OA chondrocytes. | Size: 233 Ko 17th Sep 2026 Increased Body Mass Index Among RA Patients. | Size: 229 Ko 17th Sep 2026 Low Sirtuin 1 levels in human Osteoarthritis Subchondral Osteoblasts lead to abnormal Sclerostin expression which decreases Wnt/β-catenin activity. | Size: 227 Ko 17th Sep 2026 Clinically Apparent Arterial Thrombosis in Persons with Systemic Vasculitis.